WallStreetZenWallStreetZen

NASDAQ: CAMP
Camp4 Therapeutics Corp Stock Ownership - Who owns Camp4 Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Camp4 Therapeutics Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
5am Partners VI LLC10% Owner2025-09-112,941,176$1.53
$4.50MBuy
Kelly GoldChief Financial Officer2025-09-116,060$1.65
$10.00kBuy
Josh MandelbrehmChief Executive Officer2025-09-116,060$1.65
$10.00kBuy
Yuri MaricichChief Medical Officer2025-09-116,060$1.65
$10.00kBuy
Amir NashatDirector2025-09-111,221,721$1.53
$1.87MBuy
Amir NashatDirector2025-09-1185,468$1.53
$130.77kBuy
Polaris Management Co VII LLC10% Owner2025-09-111,221,721$1.53
$1.87MBuy
Polaris Management Co VII LLC10% Owner2025-09-1185,468$1.53
$130.77kBuy
Andrew J. SchwabDirector2025-09-112,941,176$1.53
$4.50MBuy
Richard A. YoungDirector2025-09-1115,151$1.65
$25.00kBuy

1 of 1

CAMP insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CAMP insiders and whales buy or sell their stock.

CAMP Shareholders

What type of owners hold Camp4 Therapeutics Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Andrew J. Schwab16.36%8,494,236$29.05MInsider
Janus Henderson Group PLC12.15%6,307,636$21.57MInstitution
5am Venture Management LLC11.30%5,869,091$20.07MInstitution
5am Partners VI LLC11.30%5,869,091$20.07MInsider
Fmr LLC9.50%4,933,432$16.87MInstitution
Vivo Capital LLC8.18%4,246,568$14.52MInstitution
Enavate Sciences GP LLC7.29%3,785,802$12.95MInsider
Balyasny Asset Management LP5.07%2,632,437$9.00MInstitution
Northpond Ventures II GP LLC4.31%2,238,244$7.65MInsider
Enavate Sciences GP LLC4.22%2,190,920$7.49MInstitution

1 of 3

CAMP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CAMP60.47%39.53%Net Buying
ADAG5.57%1.43%
IVVD71.04%28.96%Net Selling
ARMP4.57%95.43%Net SellingNet Selling
MENS0.60%33.35%
View Top Biotech Stocks

Camp4 Therapeutics Stock Ownership FAQ

Who owns Camp4 Therapeutics?

Camp4 Therapeutics (NASDAQ: CAMP) is owned by 76.61% institutional shareholders, 50.07% Camp4 Therapeutics insiders, and 0.00% retail investors. Andrew J. Schwab is the largest individual Camp4 Therapeutics shareholder, owning 8.49M shares representing 16.36% of the company. Andrew J. Schwab's Camp4 Therapeutics shares are currently valued at $29.05M.

If you're new to stock investing, here's how to buy Camp4 Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.